Kopran's Q3 FY 2025-26 Quarterly Results

Result Summary

• Kopran Ltd reported a 64.8% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Dec (Q3 FY 2025-26). On a year-on-year (YoY) basis, it witnessed a growth of 16.8%.
• Its expenses for the quarter were up by 41.7% QoQ and 20.4% YoY.
• The net profit decreased 194.2% QoQ and decreased 10.2% YoY.
• The earnings per share (EPS) of Kopran Ltd stood at 1.93 during Q3 FY 2025-26.

Financial Statments for Q3 FY 2025-26

---

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Kopran Ltd is a prominent player in the pharmaceutical industry, known for its comprehensive range of products that include active pharmaceutical ingredients (APIs), finished dosage forms, and formulations. The company operates within the healthcare and pharmaceutical sectors, catering to both domestic and international markets. Kopran Ltd has made significant strides in enhancing its manufacturing capabilities and expanding its product portfolio. However, specific recent developments or strategic initiatives undertaken by the company are not available from the provided data.

Revenue

In the third quarter of fiscal year 2026 (Q3FY26), Kopran Ltd reported a total income of ₹194.35 crores. This marks a notable quarter-over-quarter (QoQ) increase of 64.8% from the previous quarter (Q2FY26), where the total income was ₹117.93 crores. Compared to the same quarter in the previous fiscal year (Q3FY25), there is a year-over-year (YoY) growth of 16.8% from ₹166.41 crores. This growth in revenue indicates a positive trajectory in the company's financial performance over the observed periods.

Profitability

Kopran Ltd's profitability in Q3FY26 shows a significant improvement compared to the previous quarter. The company achieved a profit before tax (PBT) of ₹10.74 crores, a substantial recovery from a loss of ₹11.63 crores in Q2FY26, reflecting a QoQ change of -192.3%. However, compared to Q3FY25, where the PBT was ₹13.86 crores, there is a YoY decline of 22.5%. The profit after tax (PAT) for Q3FY26 was ₹9.34 crores, compared to a loss of ₹9.92 crores in Q2FY26, marking a QoQ change of -194.2%. The YoY comparison shows a decrease from ₹10.40 crores in Q3FY25, a decline of 10.2%.

Operating Metrics

The total expenses for Kopran Ltd in Q3FY26 stood at ₹183.61 crores, marking a QoQ increase of 41.7% from ₹129.56 crores in Q2FY26. On a YoY basis, there was an increase of 20.4% from ₹152.56 crores in Q3FY25. The earnings per share (EPS) for this quarter was ₹1.93, compared to a negative EPS of ₹-2.06 in Q2FY26, reflecting a QoQ change of -193.7%. The YoY comparison with Q3FY25, where EPS was ₹2.15, indicates a decline of 10.2%. These financial metrics highlight the company's operational dynamics over the specified periods, providing insights into its cost management and shareholder returns.